Search Results 171-180 of 17279 for hba1c

1. A Study To Evaluate The Safety And Effectiveness Of Capivasertib + Fulvestrant Versus Placebo + Fulvestrant As Treatment For Locally Advanced (Inoperable) Or Metastatic Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Breast Cancer - Mayo Clinic

   HbA1c ≥ 8.0% (63.9 mmol/mol). Known abnormalities in coagulation such as bleeding diathesis, or treatment with anticoagulants precluding intramuscular ...

2. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

   Presence of a hemoglobinopathy or other condition that is expected to affect the measurement of HbA1c in the judgment of the investigator. Immediate family ...

3. Exercise And Low-Dose Rapamycin In Older Adults With CAD:Cardiac Rehabilitation And Rapamycin In Elderly (CARE) Trial - Mayo Clinic

   HbA1c > 13%. Any malignancy; Hematological disorder, including thrombocytopenia, leucopenia. Noncardiac illness expected to limit survival. Chronic liver ...

4. A study to test whether survodutide helps people with a liver disease called NASH/MASH who have cirrhosis - Mayo Clinic

   HbA1c > 10% (> 86 mmol/mol) as measured by the central laboratory at screening. History of T1DM or any other type than type 2 (e.g. endocrinopathy, genetic ...

5. Study Of INCB053914 In Subjects With Advanced Malignancies - Mayo Clinic

   Part 1 and Part 3 only: Hemoglobin A1c (HbA1c) > 8.0% (all subjects will have HbA1c tested at screening). Part 1 and Part 3: Any history of disease ...

6. Small bowel endoluminal bariatric and metabolic therapies - Mayo Clinic

   " DMR appears to improve glycemic control independent of weight loss," explains Dr. Badurdeen. "Participants in a multicenter study had decreases in HbA1c and ...

7. LGX818 And MEK162 In Combination With A Third Agent (BKM120, LEE011, BGJ398 Or INC280) In Advanced BRAF Melanoma - Mayo Clinic

   Patients with fasting glucose > 120 mg/dL or 6.7 mmol/L, and HbA1c > 8 %. Patient has any of the following mood disorders as judged by the. Investigator or a ...

8. A Study to Evaluate Enfortumab Vedotin to Treat Metastatic Squamous Cell Carcinoma of the Penis - Mayo Clinic

   NOTE: Uncontrolled diabetes is defined as hemoglobin A1c (HbA1c) ≥ 8.0% or HbA1c 7.0-7.9% with associated diabetes symptoms (polyuria or polydipsia) that are ...

9. Study Of Copanlisib In Combination With Standard Immunochemotherapy In Relapsed Indolent Non-Hodgkin's Lymphoma (INHL) - Mayo Clinic

   HbA1c > 8.5% at Screening. History or concurrent condition of interstitial lung disease and/or severely impaired lung function (as judged by the ...

10. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

    Uncontrolled diabetes defined as hemoglobin A1c (HbA1c) ≥ 8 or fasting blood glucose ≥ 140 mg/dL. Any of the following. History of significant ventricular ...